Delaying Pediatric Lyme Treatment: A Year Lost to Lyme Disease
Delayed treatment may worsen pediatric Lyme disease
Persistent symptoms can interfere with cognition and school performance
Timely diagnosis and treatment may help reduce long-term consequences
When this family brought their son to me, they were facing a decision many parents encounter when considering pediatric Lyme disease treatment—whether fear of antibiotics might outweigh the risk of waiting.
They were not opposed to treating Lyme disease. But fear stood in the way.
Not fear of Lyme disease itself, but fear of the treatment.
They had read about C. difficile, a potentially serious infection associated with antibiotic use. They had seen frightening stories online describing chronic diarrhea, long-term gastrointestinal complications, and even life-threatening outcomes. They also knew someone personally who had struggled to recover from C. difficile colitis.
So, when their child was diagnosed with Lyme disease and prescribed antibiotics, they hesitated.
What if the treatment made things worse?
That fear led them to wait.
Over the following year, their son developed worsening fatigue, brain fog, pain, and difficulty functioning. He ultimately lost an entire school year. His experience illustrates how delaying pediatric Lyme treatment can affect far more than physical health.
When Fear Leads to Delaying Pediatric Lyme Treatment
At first, the family tried to manage their son’s symptoms without antibiotics. They focused on diet, supplements, sleep, and stress reduction. They hoped that supporting his overall health might allow him to recover without medication.
Instead, his condition continued to deteriorate.
Fatigue deepened until it became overwhelming. Brain fog interfered with conversation and comprehension. Joint pain intensified, affecting walking, sitting, and sleep. Neuropathic pain made everyday activities increasingly difficult.
Episodes of palpitations, lightheadedness, and disorientation followed.
The child they once knew seemed to be disappearing beneath the burden of his illness.
How Delayed Pediatric Lyme Treatment Affected School
Before his illness, he was a capable and engaged student. As his symptoms worsened, school became increasingly difficult—and eventually impossible.
He struggled to concentrate and retain information. Reading and writing became exhausting. Pain made sitting through class intolerable. Absences increased, academic gaps widened, and isolation followed as he lost regular contact with friends.
The school attempted to help through extra time, tutoring, and rest periods. But accommodations could not overcome the severity of his illness. Eventually, he had to withdraw entirely.
For a full year, he watched his classmates advance academically and socially while he remained home, sick and uncertain.
Research has described problems with memory, attention, cognitive processing, attendance, and school performance in selected groups of children and adolescents with persistent symptoms following Lyme disease.
Similar challenges are discussed in my overview of pediatric Lyme disease and delayed diagnosis and my article on brain fog and cognitive dysfunction in Lyme disease.
A Year Lost to Lyme Disease
For this child, the decision to delay treatment was followed by the loss of an entire school year. The consequences extended beyond academic progress to friendships, extracurricular activities, independence, and confidence.
This case does not mean that every child whose treatment is delayed will experience the same outcome. It illustrates, however, how progressive symptoms can interfere with learning, social development, and daily functioning.
Although his health could improve, the experiences and opportunities he lost during that year could not simply be restored.
What Happened When Lyme Disease Treatment Finally Began?
By the time treatment began, the opportunity for early intervention had passed.
What might have been a more straightforward course became a prolonged and complicated recovery. His symptoms were more established, closer monitoring was required, and returning to school became a slow and uncertain process.
Many children recover after receiving appropriate antibiotic treatment. However, pediatric research shows that recovery can take longer for a smaller group of children, with some experiencing fatigue, pain, cognitive complaints, or functional impairment for six months or longer.
He did eventually return to school.
But the year he lost—academically, socially, and emotionally—could not be recovered.
What Research Shows About Long-Term Symptoms in Children
Monaghan and colleagues evaluated 102 children who had been diagnosed with Lyme disease between six months and 10 years before enrollment. Most children ultimately recovered, but 22% experienced at least one symptom lasting longer than six months. Nine percent had persistent symptoms accompanied by functional impairment.
Children meeting the study’s criteria for post-treatment Lyme disease syndrome had greater fatigue and lower parent-reported physical quality-of-life scores. The study offers reassurance that most children recover while also documenting prolonged symptoms and functional limitations in a smaller group.
Bloom and colleagues described neurocognitive abnormalities in children who developed cognitive symptoms during or after classic manifestations of Lyme disease. Reported difficulties involved areas such as memory, attention, and processing. Because these children were evaluated for neurocognitive concerns, the findings should not be interpreted as representing every child with Lyme disease.
McAuliffe and colleagues compared 25 adolescents with late-stage post-treatment Lyme disease and symptoms lasting longer than six months with 25 matched adolescents without Lyme disease. The Lyme disease group demonstrated difficulties involving visual and verbal memory and had poorer attendance and grades. The groups did not differ in academic achievement before illness or in depression.
Together, these pediatric studies show that most children recover, but a subset may experience prolonged fatigue, cognitive difficulties, reduced physical functioning, and disruption of school performance.
What Parents Should Know About Delaying Treatment
Antibiotic risks deserve thoughtful consideration. Parents must also consider the potential consequences of allowing a confirmed or clinically diagnosed Lyme infection to remain untreated.
Untreated Lyme disease can disseminate and involve the joints, heart, or nervous system. Depending on the manifestation, a child may develop arthritis, facial palsy, meningitis, carditis, or other complications.
Some children also experience prolonged fatigue, pain, cognitive difficulties, or reduced stamina that interferes with education and daily life. Symptoms such as lightheadedness, palpitations, exercise intolerance, and difficulty concentrating may warrant evaluation for autonomic dysfunction associated with Lyme disease or another medical condition.
Antibiotic risks can be addressed through appropriate prescribing, careful monitoring, and prompt attention to adverse effects. Treatment decisions should be individualized and made with a clinician who understands both the potential benefits and risks.
Frequently Asked Questions
Can children have long-term symptoms after Lyme disease?
Yes. Most children recover, but pediatric research has documented symptoms lasting longer than six months in a subset of children. These may include fatigue, pain, cognitive complaints, and reduced physical functioning.
Can Lyme disease affect a child’s school performance?
Yes. In selected groups of children and adolescents with persistent symptoms, researchers have reported memory difficulties, poorer attendance, lower grades, and problems with school functioning.
Does every child develop persistent symptoms after Lyme disease?
No. Most children recover fully. In one pediatric study, 22% had at least one symptom lasting longer than six months, while 9% had prolonged symptoms accompanied by functional impairment.
Can delaying pediatric Lyme treatment lead to a longer recovery?
Early treatment is generally associated with favorable outcomes. The length of recovery varies, however, and some children experience symptoms for months. Pediatric studies document prolonged symptoms but do not establish that every long-term problem is caused specifically by a treatment delay.
What are the risks of untreated Lyme disease in children?
Untreated Lyme disease can spread to the joints, heart, or nervous system. Possible manifestations include Lyme arthritis, facial palsy, meningitis, carditis, and other neurologic or systemic complications.
Clinical Takeaway
Most children treated for Lyme disease recover fully. Nevertheless, pediatric studies show that a smaller group experiences symptoms lasting six months or longer, sometimes with fatigue, cognitive difficulties, reduced physical functioning, and impaired school performance.
Parents should consider both the risks of antibiotic treatment and the risks of leaving Lyme disease untreated. Treatment decisions should be timely, individualized, and made in consultation with an experienced clinician.
A year lost to Lyme disease can affect far more than physical health. Early recognition, informed decision-making, and appropriate treatment may help reduce disruption to a child’s education, development, and quality of life.
Related Articles
- Pediatric Lyme disease and delayed diagnosis
- Brain fog and cognitive dysfunction in Lyme disease
- Recovery from Lyme disease
- What does Lyme disease do to your brain?
References:
- Monaghan M, Norman S, Gierdalski M, et al. Pediatric Lyme disease: Systematic assessment of post-treatment symptoms and quality of life. Pediatric Research. 2024;95(1):174–181.
- Bloom BJ, Wyckoff PM, Meissner HC, Steere AC. Neurocognitive abnormalities in children after classic manifestations of Lyme disease. Pediatric Infectious Disease Journal. 1998;17(3):189–196.
- McAuliffe P, Brassard MR, Fallon B. Memory and executive functions in adolescents with posttreatment Lyme disease. Applied Neuropsychology. 2008;15(3):208–219.
This information is provided for educational purposes and is not a substitute for medical advice, diagnosis, or treatment.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
